Project Area Z

Clinical translational unit

 

Z02

Clinical Translation Coordinator

Prof. Dr. Luisa Klotz
Klinik für Neurologie mit Institut für Translationale Neurologie
der Westfälischen Wilhelms-Universität Münster

Prinipal Investigators

Prof. Prof. h.c. Dr. Heinz Wiendl
Klinik für Neurologie mit Institut für Translationale Neurologie
der Westfälischen Wilhelms-Universität Münster

 
Prof. Dr. Ralf Gold
Neurologische Klinik, St.-Josef-Hospital
der Ruhr-Universität Bochum

 
Prof. Dr. Bernhard Hemmer
Neurologische Klinik und Poliklinik
Klinikum rechts der Isar
Technischen Universität München

 
Prof. Dr. Reinhard Hohlfeld
Institut für Klinische Neuroimmunologie
Ludwig-Maximilians-Universität München

 
Prof. Dr. Frauke Zipp
Klinik und Poliklinik für Neurologie
Universitätsmedizin der Johannes Gutenberg-Universität Mainz

 

 

 

News

Tue, 22/10/2019
The key lies in cell metabolism: Neuroscientist and neurologist Luisa Klotz wins renowned Heinrich-Pette-Award
Münster. For the third time the renowned neuroscience award “Heinrich Pette prize” goes to Münster, as this year Luisa Klotz was rewarded with the prestigious award for neuroscience researchers and clinicians at the congress of the German Society of Neurology in Stuttgart. Neurologist and Neuroscientist Luisa Klotz received the award for her outstanding research in […]...more
Mon, 07/10/2019
Talk “Der Einfluss der Ernährung und des Darms auf die Multiple Sklerose”
Muenster. The department of neurology with Institute of Translational Neurology warmly welcomes SFB 128-PI Prof. Aiden Haghikia, leading senior physician at the Department of Neurology at Bochum University Clinic. His talk “Der Einfluss der Ernährung und des Darms auf die Multiple Sklerose” provides insights into his latest research progress in this field. Time: Wednesday, October […]...more
Mon, 03/06/2019
Publication: Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.
Muenster. For the first time scientists from the University of Münster could show that multiple sclerosis (MS) alters the energy metabolism of T cells during acute phases of disease exacerbation. Therapeutic interventions targeting the metabolism of activated T cells display new potential avenues for treatment of patients with MS affecting around 250,000 people in Germany. The […]...more